| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |